Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amway on China

This article was originally published in The Rose Sheet

Executive Summary

Without a U.S. normal trade relations status designation for China, tariffs on domestic imports could increase 30% to 50%, Chairman Steve Van Andel states in comments before the House Ways & Means/Trade Subcommittee June 8. Van Andel spoke on behalf of the U.S. Chamber of Commerce to urge the committee to normalize trade relations with China and support its accession to the World Trade Organization. The U.S./China trade agreement, signed April 10, would lift the direct sales ban in China by 2003 ("The Rose Sheet" April 19, p. 9). The agreement remains subject to approval by Congress and President Clinton. Amway China, which commenced operations in 1995, is one of the country's largest investors, with 1997 consolidated sales of $178 mil. and over 500,000 Chinese distributors. Amway has invested $100 mil. in China over the past five years ("The Rose Sheet" June 15, 1998, p. 4)

You may also be interested in...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Chart: Weekly Trademark Review -- Nov. 2, 2010

Weekly Trademark Review



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts